Fitbit Collaborates with BMS-Pfizer Alliance Focusing on Improving Atrial Fibrillation Detection

 Fitbit Collaborates with BMS-Pfizer Alliance Focusing on Improving Atrial Fibrillation Detection

Fitbit Collaborates with BMS-Pfizer Alliance Focusing on Improving Atrial Fibrillation Detection

Shots:

  • The BMS-Pfizer Alliance and Fitbit collaborate to develop educational content and guidance, supporting patients with a high risk of AFib. The companies will focus on providing information to encourage patients to have a discussion with their physicians, following the FDA clearance of AFib detection software on Fitbit devices
  • The collaboration helps to bridge the gaps existing in AFib detection and reducing risk of stroke with its 24/7 on-wrist health tracking capabilities and experience of delivering personalized, engaging software and services
  • Fitbit’s wearable technology provide motivation for everyday health and fitness and includes products like Fitbit Charge 3, Fitbit Inspire HR, Fitbit Inspire, Fitbit Ace 2 activity trackers, as well as the Fitbit Ionic & Fitbit Versa smartwatches, Fitbit Flyer wireless headphones & Fitbit Aria family of smart scales

Click here to­ read full press release/ article | Ref: BMS | Image: Amazon

Shiwani Sharma

Shiwani Sharma is a Senior Editor at PharmaShots. She has in-depth knowledge of lifesciences industry including pharma and biotech sectors. She also covers news in field of Digital Health, Medtech and regulatory approvals from the US FDA, EU, and other global regulatory bodies in the industry. Additionally, she also writes Whitepapers, analysis reports, blogs on pharma and biotech industry. She is graduate in Biotechnology. She can be contacted on shiwani@pharmashots.com

Related post